Senior Director, Global Scientific Content at Acadia Pharmaceuticals

Conshohocken, Pennsylvania, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Leadership experience in scientific content development within Medical Affairs or similar biopharmaceutical roles
Expertise in aligning scientific content with Medical Affairs strategies and communication platforms
Ability to oversee creation, adaptation, and distribution of global scientific content across multiple channels
Knowledge of digital and omnichannel content strategies for HCP engagement
Strong commitment to scientific accuracy, rigor, and compliance standards
Experience ensuring alignment with training programs for field medical teams
Skills in gathering insights from training metrics and feedback to refine content
Proven team leadership, inspiration, and development capabilities
Ability to define, prioritize, and execute global scientific content plans with budgets and interdependencies
Hybrid work availability (three days per week in Conshohocken, PA)

Responsibilities

Define and prioritize global scientific content needs for internal (e.g., Field Medical, Health Systems) and external stakeholders (e.g., HCPs)
Ensure scientific content planning aligns with Madrigal Medical Affairs strategies, Scientific Communication platforms, and training plans
Create and execute the annual global scientific content plan, including tactics, interdependencies, ownership, and budget
Oversee creation, adaptation, and distribution of global content across channels for consistent scientific exchange
Support development of comprehensive content strategies leveraging digital/omnichannel approaches within compliance
Ascertain scientific accuracy, stakeholder relevance, and appropriateness of content formats
Champion scientific rigor and data-driven decision-making
Ensure alignment of content with global scientific training programs for field medical and other stakeholders
Gather insights from training evaluations (metrics and feedback) to inform content improvements
Lead, inspire, and develop the team (~60% effort on direction and strategic adaptation; ~40% on execution)

Skills

Key technologies and capabilities for this role

Scientific Content DevelopmentMedical AffairsScientific CommunicationsContent StrategyStakeholder EngagementHealthcare Professionals CommunicationGlobalization of ContentField Medical Support

Questions & Answers

Common questions about this position

Is this a remote role or does it require office presence?

This is a hybrid role requiring three days per week at the Conshohocken, PA office.

What is the salary or compensation for this position?

This information is not specified in the job description.

What are the key responsibilities of the Senior Director, Global Scientific Content?

The role involves leading the development and execution of scientific content, contributing to Medical Affairs and Scientific Communication Plans, partnering with Medical Affairs for high-quality content delivery, and overseeing strategic planning, alignment, and content development across channels.

What is the company culture like at Madrigal?

Madrigal is building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration.

What makes a strong candidate for this role?

Strong candidates will have leadership experience in scientific content development, strategic planning skills aligned with Medical Affairs, and the ability to oversee global content execution while directing teams.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free